THROMBOCYTOPENIA IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - TREATMENT UPDATE
被引:30
作者:
GLATT, AE
论文数: 0引用数: 0
h-index: 0
机构:
HARVARD UNIV, NEW ENGLAND DEACONESS HOSP, SCH MED, DIV HEMATOL & ONCOL, BOSTON, MA 02215 USAHARVARD UNIV, NEW ENGLAND DEACONESS HOSP, SCH MED, DIV HEMATOL & ONCOL, BOSTON, MA 02215 USA
GLATT, AE
[1
]
ANAUD, A
论文数: 0引用数: 0
h-index: 0
机构:
HARVARD UNIV, NEW ENGLAND DEACONESS HOSP, SCH MED, DIV HEMATOL & ONCOL, BOSTON, MA 02215 USAHARVARD UNIV, NEW ENGLAND DEACONESS HOSP, SCH MED, DIV HEMATOL & ONCOL, BOSTON, MA 02215 USA
ANAUD, A
[1
]
机构:
[1] HARVARD UNIV, NEW ENGLAND DEACONESS HOSP, SCH MED, DIV HEMATOL & ONCOL, BOSTON, MA 02215 USA
Thrombocytopenia that is associated with infection due to human immunodeficiency virus (HIV) is an important and common hematologic abnormality. Although this condition is often asymptomatic, it may manifest clinically as a spectrum of bleeding problems including petechiae, ecchymoses, epistaxis, or menorrhagia or as hemorrhage of the gingivae, gastrointestinal tract, or CNS. Thrombocytopenia may be present in patients at any stage of immunodeficiency, and spontaneous remission can occur. We review the natural history of HIV-related thrombocytopenia and discuss treatment options.